ARCHIVES  |  CONTACT  | SERVICES  | HOME

Welcome To

CEOCFOmobile

 

CEOCFO-Members Login

 

December 11, 2017 Issue

CEOCFO MAGAZINE

 

Free Adobe PDF Reader for Android/Kindle, iPad/iPhone

http://www.adobe.com/products/reader-mobile.html

 



Eric​ ​Marcotulli - Elysium​ ​Health

Elysium​ ​Health​ ​CEO,​ ​Eric​ ​Marcotulli,​ ​Wants​ ​to​ ​Solve​ ​the​ Biggest​ ​Challenges​ ​in​ ​Health​ ​-​ ​And Hes​ ​Got​ ​a​ ​Plan​ ​to​ ​Do​ ​It

Print Version - PDF  Mobile Download - PDF


Potentia Analytics, Inc.

A leading provider of advanced workforce and workflow optimization solutions for healthcare including Intelligent Provider Scheduling, ER Patient Flow Optimization and a Policy and Decision-making module.

Print Version - PDF  Mobile Download - PDF


Onconova Therapeutics (Nasdaq: ONTX)

With their drug Rigosertib now in Phase III Trials for the Bone Marrow Disorder Myelodysplastic Syndrome used in over 500 Patients, Onconova Therapeutics brings hope to many Elderly Suffering from this Devastating Disease

Print Version - PDF  Mobile Download - PDF


RxDataScience Inc.

Applying Data Science and Predictive Analytics to the Healthcare Data for Improving Patient Outcomes and Lowering Costs

Print Version - PDF  Mobile Download - PDF


DNotes Global, Inc.

DNotes Global, Inc. is focused on Bringing DNotes Digital Currency Mainstream with a Platform and Ecosystem that will give it Intrinsic Value just as Cash

Print Version - PDF  Mobile Download - PDF


SuitX

suitX Exoskeletons Increasing Safety and Productivity for Workers in Delivery, Industrial, and Construction and Provides Mobility for Individuals with Spinal Cord Injuries and Stroke

Print Version - PDF  Mobile Download - PDF


Thunder Energies Corporation (OTC PINK: TNRG)

Revolutionary New Technology for Detecting Smuggled Nuclear Weapons

Print Version - PDF  Mobile Download - PDF


Afecta Pharmaceuticals

Creating New Drugs Based on Safe Existing Compounds Using a Systems Biology Based, Computationally Driven Pharmacometric Platform with Current Programs in Inflammatory Diseases such as Atopic Dermatitis and Psoriasis

Print Version - PDF  Mobile Download - PDF


Caladrius Biosciences, Inc. (NASDAQ:CLBS)

Individualized Cell Therapy Medicine and Manufacturing with an Immunomodulation Platform using T-Regulatory Cells for Program in Type 1 Diabetes Mellitus

Print Version - PDF  Mobile Download - PDF


ChristianSteven Software

Delivering Business Intelligence: Empowering users to Automate, Streamline, Analyze and Predict

Print Version - PDF  Mobile Download - PDF


KomBea

New Call Center Technology providing Dynamic Answers to Questions at the Push of a Button eliminating Human Error

Print Version - PDF Mobile Download - PDF


Lomiko Metals Inc.-

Graphene Incubator focused on Technology, developing Electronic Devices and their Lalutra Graphite Property

Print Version - PDF  Mobile Download - PDF




 


 

 

 

 

 










 



Eric​ ​Marcotulli - Elysium​ ​Health
www.elysiumhealth.com


 



www.potentiaco.com
www.potentiaanalytics.com

 




www.onconova.com
http://www.fdareview.org/03_drug_development.php

    stock quote  |  faqs


 

Micro-applications

Analytics as a Service

Data Science Consulting


www.rxdatascience.com
twitter - facebook




www.dnotescoin.com
twitter - facebook
blog




www.suitx.com
news




www.thunder-energies.com

news - investors




www.afectapharm.com
news



www.caladrius.com
twitter - facebook
linkedin - youtube

investor overview

news - events



www.christiansteven.com

blog

 

 

Learn About SecureCall Benefits

www.kombea.com
linkedin - blog

news

 

 



disclaimers

Any reproduction or further distribution of this article without the express written consent of CEOCFOinterviews.com is prohibited.

 

CEOCFO mobile for Mobile Phones and eBook Readers - Executive Interviews formatted and available in htm/html and PDF and formats for Downloading on Android, Cell Phones, iPhones, iPads, Kindle, Nook and other eReader devices

Find ways to enhance your business with the latest in technology and services, new developments in drugs, medical devices, diagnostics, cancer therapies, CROs, Clinical Trial and healthcare services, investment and funding opportunities, companies with capital

 

ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.